Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Jul 1;158(1):146–158. doi: 10.1084/jem.158.1.146

Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes

PMCID: PMC2187067  PMID: 6190975

Abstract

The immunogenic Plasmodium knowlesi (H strain) Mr 74,000 protein in membranes of schizont-infected rhesus erythrocytes was purified on a large scale, free of other polypeptides as monitored by dodecyl sulfate polyacrylamide gel electrophoresis and isoelectric focusing. In a limited vaccination trial, four rhesus monkeys were immunized four consecutive times with the Mr 74,000 protein and Freund's complete and incomplete adjuvants. Two monkeys were injected with adjuvant only. Upon challenge with 10(4) viable P. knowlesi schizonts of the heterologous W strain, the control monkeys developed fatal parasitemias after 7 d. In contrast, the vaccinated monkeys exhibited a delayed onset of patent parasitemias and underwent self-cure on days 14 to 16 after peak parasitemias of between 7 and 11%. The protective immunity that was induced crossed different strains of P. knowlesi. Blood smears at the time of cure demonstrated limited reinfection, as indicated by the presence of normally appearing ring and trophozoite stages. The absence of schizont stages in the peripheral blood suggested a specific interruption of the erythrocytic schizogony at that stage. Immunochemical analyses of the rhesus sera revealed antibody only against the Mr 74,000 protein after the first two immunizations. Upon repeated antigen injection, antibodies reacted with components of Mr of approximately 102,000, 140,000, and 230,000 in addition to the Mr 74,000 protein. Besides immunological cross-reactivity, relatedness between all four immune-precipitated proteins was indicated by a greater than 50% tryptic peptide homology, suggesting that the Mr 230,000 component represents a precursor protein that is cleaved within the infected erythrocyte into proteins with Mr of approximately 140,000, 102,000, and 74,000.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnwell J. W., Howard R. J., Miller L. H. Altered expression of Plasmodium knowlesi variant antigen on the erythrocyte membrane in splenectomized rhesus monkeys. J Immunol. 1982 Jan;128(1):224–226. [PubMed] [Google Scholar]
  2. Brown G. V., Anders R. F., Mitchell G. F., Heywood P. F. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro. Nature. 1982 Jun 17;297(5867):591–593. doi: 10.1038/297591a0. [DOI] [PubMed] [Google Scholar]
  3. Brown K. N., Brown I. N. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature. 1965 Dec 25;208(5017):1286–1288. doi: 10.1038/2081286a0. [DOI] [PubMed] [Google Scholar]
  4. Butcher G. A., Cohen S. Antigenic variation and protective immunity in Plasmodium knowlesi malaria. Immunology. 1972 Oct;23(4):503–521. [PMC free article] [PubMed] [Google Scholar]
  5. COHEN S., McGREGOR I. A., CARRINGTON S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961 Nov 25;192:733–737. doi: 10.1038/192733a0. [DOI] [PubMed] [Google Scholar]
  6. Chulay J. D., Aikawa M., Diggs C., Haynes J. D. Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures. Am J Trop Med Hyg. 1981 Jan;30(1):12–19. doi: 10.4269/ajtmh.1981.30.12. [DOI] [PubMed] [Google Scholar]
  7. Coggeshall L. T., Kumm H. W. DEMONSTRATION OF PASSIVE IMMUNITY IN EXPERIMENTAL MONKEY MALARIA. J Exp Med. 1937 Jul 31;66(2):177–190. doi: 10.1084/jem.66.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deans J. A., Dennis E. D., Cohen S. Antigenic analysis of sequential erythrocytic stages of Plasmodium knowlesi. Parasitology. 1978 Dec;77(3):333–344. doi: 10.1017/s0031182000050290. [DOI] [PubMed] [Google Scholar]
  9. Diggs C. L., Osler A. G. Humoral immunity in rodent malaria. III: Studies on the site of antibody action. J Immunol. 1975 Apr;114(4):1243–1247. [PubMed] [Google Scholar]
  10. Elder J. H., Pickett R. A., 2nd, Hampton J., Lerner R. A. Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. J Biol Chem. 1977 Sep 25;252(18):6510–6515. [PubMed] [Google Scholar]
  11. Freeman R. R., Trejdosiewicz A. J., Cross G. A. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature. 1980 Mar 27;284(5754):366–368. doi: 10.1038/284366a0. [DOI] [PubMed] [Google Scholar]
  12. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gwadz R. W., Green I. Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi. J Exp Med. 1978 Nov 1;148(5):1311–1323. doi: 10.1084/jem.148.5.1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Holder A. A., Freeman R. R. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature. 1981 Nov 26;294(5839):361–364. doi: 10.1038/294361a0. [DOI] [PubMed] [Google Scholar]
  15. Kilejian A. Histidine-rich protein as a model malaria vaccine. Science. 1978 Sep 8;201(4359):922–924. doi: 10.1126/science.567375. [DOI] [PubMed] [Google Scholar]
  16. Kilejian A. Plasmodium lophurae: immunogenicity of a histidine-rich protein. Exp Parasitol. 1981 Oct;52(2):291–291. doi: 10.1016/0014-4894(81)90084-9. [DOI] [PubMed] [Google Scholar]
  17. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  18. Mendis K. N., Targett G. A. Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite. Nature. 1979 Feb 1;277(5695):389–391. doi: 10.1038/277389a0. [DOI] [PubMed] [Google Scholar]
  19. Miller L. H., Johnson J. G., Schmidt-Ullrich R., Haynes J. D., Wallach D. F., Carter R. Determinants on surface proteins of Plasmodium knowlesi merozoites common to Plasmodium falciparum schizonts. J Exp Med. 1980 Apr 1;151(4):790–798. doi: 10.1084/jem.151.4.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mitchell G. H., Butcher G. A., Langhorne J., Cohen S. A freeze-dried merozoite vaccine effective against Plasmodium knowlesi malaria. Clin Exp Immunol. 1977 May;28(2):276–279. [PMC free article] [PubMed] [Google Scholar]
  21. Perrin L. H., Dayal R. Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response. Immunol Rev. 1982;61:245–269. doi: 10.1111/j.1600-065x.1982.tb00379.x. [DOI] [PubMed] [Google Scholar]
  22. Perrin L. H., Dayal R., Rieder H. Characterization of antigens from erythrocytic stages of Plasmodium falciparum reacting with human immune sera. Trans R Soc Trop Med Hyg. 1981;75(1):163–165. doi: 10.1016/0035-9203(81)90055-9. [DOI] [PubMed] [Google Scholar]
  23. Perrin L. H., Ramirez E., Lambert P. H., Miescher P. A. Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature. 1981 Jan 22;289(5795):301–303. doi: 10.1038/289301a0. [DOI] [PubMed] [Google Scholar]
  24. Potocnjak P., Yoshida N., Nussenzweig R. S., Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med. 1980 Jun 1;151(6):1504–1513. doi: 10.1084/jem.151.6.1504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Resch K., Imm W., Ferber E., Wallach D. F., Fischer H. Quantitative determination of soluble and membrane proteins through their native fluorescence. Naturwissenschaften. 1971 Apr;58(4):220–220. doi: 10.1007/BF00591853. [DOI] [PubMed] [Google Scholar]
  26. Schmidt-Ullrich R., Miller L. H., Wallach D. F., Lightholder J. Immunogenic antigens common to Plasmodium knowlesi and Plasmodium falciparum are expressed on the surface of infected erythrocytes. J Parasitol. 1982 Apr;68(2):185–193. [PubMed] [Google Scholar]
  27. Schmidt-Ullrich R., Miller L. H., Wallach D. F., Lightholder J., Powers K. G., Gwadz R. W. Rhesus monkeys protected against Plasmodium knowlesi malaria produce antibodies against a 65,000-MrP. knowlesi glycoprotein at the surface of infected erythrocytes. Infect Immun. 1981 Nov;34(2):519–525. doi: 10.1128/iai.34.2.519-525.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schmidt-Ullrich R., Thompson W. S., Kahn S. J., Monroe M. T., Wallach D. F. Simian virus 40 (SV40)-specific isoelectric point-4.7--94,000-Mr membrane glycoprotein: major peptide homology exhibited with the nuclear and membrane-associated 94,000-Mr SV40 T-antigen in hamsters. J Natl Cancer Inst. 1982 Oct;69(4):839–849. [PubMed] [Google Scholar]
  29. Schmidt-Ullrich R., Wallach D. F., Lightholder J. Fractionation of Plasmodium knowlesi-induced antigens of rhesus monkey erythrocyte membranes. Bull World Health Organ. 1979;57 (Suppl 1):115–121. [PMC free article] [PubMed] [Google Scholar]
  30. Schmidt-Ullrich R., Wallach D. F. Plasmodium knowlesi-induced antigens in membranes of parasitized rhesus monkey erythrocytes. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4949–4953. doi: 10.1073/pnas.75.10.4949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sherman I. W. Plasmodium lophurae: protective immunogenicity of the histidine-rich protein? Exp Parasitol. 1981 Oct;52(2):292–295. doi: 10.1016/0014-4894(81)90085-0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES